Primary Health Props - Director/PDMR Shareholding

Primary Health Properties

26/01/2026 12:30

RNS Number : 3710Q

Primary Health Properties PLC

26 January 2026

 

Primary Health Properties PLC

("PHP" or the "Company"),

 

 

Director/PDMR Shareholding

 

 

The Company has been notified that the following information relating to the transaction detailed below has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation.

1
Details of person discharging managerial responsibilities/person closely associated
(a)
Name
Laure Duhot
2
Reason for notification
(a)
Position/Status
Non-executive Director
(b)
Initial notification/amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)
Name
Primary Health Properties PLC
(b)
LEI
213800Y5CJHXOATK7X11
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)
Description of the financial instrument
Ordinary shares of 12.5p
ISIN: GB00BYRJ5J14
(b)
Nature of the transaction
Nil cost transfer of shares from PCA to Laure Duhot
(c)
Price(s) and volume(s)
Price(s)
Volume(s)
Nil
23,169
(d)
Aggregated volume
Price
23,169
Nil
(e)
Date of transaction
22 January 2026
(f)
Place of transaction
Outside of a trading venue

 

For further information

Primary Health Properties PLC

 

Toby Newman, Company Secretary & Chief Legal Officer

+44(0) 7729 047 959

 

Legal Entity Identifier: 213800Y5CJHXOATK7X11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHBGGDBRUDDGLL